Genzyme Tops Cobrek In Kidney Drug Patent Fight
An Illinois federal judge ruled Thursday that a Genzyme Corp. patent covering kidney disease treatment Hectorol is valid and enforceable in the drugmaker's suit against Cobrek Pharmaceuticals Inc. over a generic...To view the full article, register now.
Already a subscriber? Click here to view full article